Fund moves
68 tracked managers disclosed the same change for Q4 2025. From a 13F filed Jan 14, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Transaction Nov 18, 2025 · Disclosed Dec 15, 2025
2 different filers disclosed REGN within 90 days. Disclosed 27 days after the transaction; reported as an official range, not an exact amount.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
$1,001–$15,000
Official band as filed. No midpoint or exact amount is implied
Filer
27 days
Days between the transaction date and the filing date
First disclosure on this company by this filer
2 distinct filers within 90 days
Closed at $725.34 on Nov 18, 2025, 50% above its 52-week low and 8% below its high, after a 24% rise over the previous 30 trading days
52-week range $483.07 (Jun 5, 2025) to $788.00 (Dec 9, 2024), 79% of the way up, from 250 adjusted closes. 30 trading days earlier: $583.24 on Oct 7, 2025. Describes the past only, not a forecast
RSI 80, 22% above its 200-day average, 20% above its 50-day average, 8% below the 52-week high, 20-day volatility 44% a year, against the S&P 500: +27 points over 1 month, +19 points over 3 months, +7 points over 6 months
From the adjusted closes up to Nov 18, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Fund moves
68 tracked managers disclosed the same change for Q4 2025. From a 13F filed Jan 14, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Insider filing
Traded Jan 7 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Bonnie L Bassler (Director) sold ~$1.2M of Regeneron Pharmaceuticals
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.